Morgan Stanley’s Tenaya Therapeutics TNYA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$186K Buy
268,505
+60,074
+29% +$44.3K ﹤0.01% 5905
2025
Q4
$148K Buy
208,431
+41,342
+25% +$56.2K ﹤0.01% 6042
2025
Q3
$271K Buy
167,089
+51,210
+44% +$51.6K ﹤0.01% 5763
2025
Q2
$70.8K Sell
115,879
-198,670
-63% -$101K ﹤0.01% 6244
2025
Q1
$179K Sell
314,549
-1,173,757
-79% -$1.16M ﹤0.01% 5774
2024
Q4
$2.13M Buy
1,488,306
+1,175,315
+376% +$2.63M ﹤0.01% 4651
2024
Q3
$604K Buy
312,991
+135,268
+76% +$382K ﹤0.01% 5310
2024
Q2
$551K Sell
177,723
-138,166
-44% -$571K ﹤0.01% 5248
2024
Q1
$1.65M Sell
315,889
-148,123
-32% -$709K ﹤0.01% 4690
2023
Q4
$1.5M Buy
464,012
+379,989
+452% +$820K ﹤0.01% 5101
2023
Q3
$214K Sell
84,023
-28,344
-25% -$119K ﹤0.01% 5551
2023
Q2
$660K Buy
112,367
+31,948
+40% +$186K ﹤0.01% 5078
2023
Q1
$229K Buy
80,419
+52,559
+189% +$148K ﹤0.01% 5652
2022
Q4
$56K Buy
27,860
+13,601
+95% +$33.2K ﹤0.01% 6244
2022
Q3
$41K Buy
14,259
+1,158
+9% +$5.4K ﹤0.01% 6494
2022
Q2
$75K Buy
13,101
+1,564
+14% +$12.7K ﹤0.01% 6414
2022
Q1
$135K Sell
11,537
-18,661
-62% -$226K ﹤0.01% 6137
2021
Q4
$572K Buy
30,198
+27,132
+885% +$591K ﹤0.01% 5464
2021
Q3
$63K Buy
+3,066
New +$65.9K ﹤0.01% 6612

Other funds holding TNYA